Article
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives
17 Mar 2023
Abstract excerpt
Some cancer patients display a less aggressive form of metastatic disease, characterized by a low tumor burden and involving a smaller number of sites, which is referred to as “oligometastatic disease” (OMD). This review discusses new biomarkers, as well as methodological challenges and perspectives characterizing OMD. Recent studies have revealed that specific microRNA profiles, chromosome patterns, driver gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
